Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.
about
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving ConceptsRaltegravir for the treatment of HIV infection in adults and childrenBlocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responsesScreening for and verification of novel mutations associated with drug resistance in the HIV type 1 subtype B(') in ChinaAdherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort StudySuboptimal antiretroviral therapy adherence among HIV-infected adults in Guangzhou, China.Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study.Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial.Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy.Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies.Clinic Attendance for Medication Refills and Medication Adherence amongst an Antiretroviral Treatment Cohort in Uganda: A Prospective Study.Facility-level intervention to improve attendance and adherence among patients on anti-retroviral treatment in Kenya--a quasi-experimental study using time series analysis.Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance.Virtual intervention to support self-management of antiretroviral therapy among people living with HIV.Factors associated with self-reported adherence among adolescents on antiretroviral therapy in Zimbabwe.The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.Effect of an Empowerment Intervention on Antiretroviral Drug Adherence in Thai Youth.Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected women.Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling.HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.Alcohol Consumption, Progression of Disease and Other Comorbidities, and Responses to Antiretroviral Medication in People Living with HIV.EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment.Improving HIV/AIDS care through treatment advocacy: going beyond client education to empowerment by facilitating client-provider relationships.Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria.HIV Stigma in Prisons and Jails: Results from a Staff Survey.Antiretroviral dynamics determines HIV evolution and predicts therapy outcome.A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugsEvaluation of a real-time virtual intervention to empower persons living with HIV to use therapy self-management: study protocol for an online randomized controlled trial.Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia.Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.Medication-taking self-efficacy and medication adherence among HIV-infected cocaine users.Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication.Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals.Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China.Language and Culture in Health Literacy for People Living with HIV: Perspectives of Health Care Providers and Professional Care Team Members.Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines.
P2860
Q22241321-9BB7FD3D-D181-4989-BBA2-93F0D8A280FAQ24186953-1EC3177F-C724-467B-80C8-A43203736652Q26774878-6F3277EC-BE7C-440A-8DA2-4904BBDD7630Q28485108-B3E2A064-024C-4888-9F80-CFDA881C746EQ28534423-2C9F245D-4943-4CB6-8149-16C3631134C1Q33623993-C79FDC60-BBA5-45DB-B63D-608CEBC47E82Q33787631-0428FAC5-941D-409B-BDB6-58EEAFC8D44FQ33814942-2D8E87CD-42F4-47FB-8144-47BC210E1663Q33917546-630E0C4F-3C13-499A-9DE2-3F2698E45A92Q34468059-2B8A4307-ADE2-439B-98CC-073D9708DC9CQ34605871-E7081EB9-5298-4CF0-B138-07630DBB4E56Q34729754-7900DD7B-970B-4923-9F92-FB122641108AQ34788589-4062A736-6CCE-4D7F-99D0-BA3AB95EDAF4Q34875358-69B39BCD-8BC0-41C9-95E7-E48849F57C72Q34937254-E9E25BE0-A144-4053-94FD-ACA3C7FD50D0Q34974447-D983CE2E-B6DC-42F8-9EAE-953B9204C5ACQ35009707-834CDFB7-9D03-4056-B84B-81D51D0A8F43Q35019915-A03C6A4D-ADC7-4E31-8545-F3CA794496E8Q35220508-54A84E5E-E6E6-4FE1-98E7-766EE1161075Q35230243-D3978258-6AB1-4419-9A5E-93300C9FDCD2Q35364313-199059DD-2F91-4D48-BE8D-F9019F5DC942Q35686969-53DD0AFA-EF31-451D-BE1B-063997A1C667Q35846104-F5092667-9EEB-4A21-AE9B-A0C2C981DCE5Q35921909-DF8E86EF-EE0E-4A47-9DF1-DEE9BF405DF1Q36161726-D4082670-02B3-405D-9373-DF73D4B23123Q36226907-6979F2B5-C025-48E3-B8D6-A5D686B8598CQ36302953-E6080934-BD11-4FC0-A992-0868FA3D7D7DQ36345603-43004053-6D16-4920-88E3-0E180BC8446BQ36374300-A9B02DFF-BE78-4568-835E-21BA8B872E30Q36390767-0867AF09-908C-4094-AB34-AED2788380B4Q36459450-DA3AE542-F378-4B22-A987-02B8011DCFECQ36506174-C50D99D8-8AF5-4D10-A69A-C7B531A61721Q36554980-67BFACB6-9ACA-487E-A909-E038C8022C3AQ36639722-30EC01CA-AEBC-451B-84EA-6959A2092AF7Q36666541-3ADBE566-38F0-4493-BF24-983FFDC4991EQ36882901-C7C60135-591E-4907-A151-CBF517486DCAQ36892497-C2A89642-5C8E-4EEF-86DA-CD915354390DQ36959418-43577E4E-E9D9-4333-B6E3-EBE22B7D205EQ37009879-35259372-7FB0-45DD-901C-3CAD849DA520Q37077894-166100DE-6AD8-40D2-9296-C89B31A7BC71
P2860
Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiretroviral medication adhe ...... fic antiretroviral resistance.
@en
Antiretroviral medication adhe ...... fic antiretroviral resistance.
@nl
type
label
Antiretroviral medication adhe ...... fic antiretroviral resistance.
@en
Antiretroviral medication adhe ...... fic antiretroviral resistance.
@nl
prefLabel
Antiretroviral medication adhe ...... fic antiretroviral resistance.
@en
Antiretroviral medication adhe ...... fic antiretroviral resistance.
@nl
P2093
P2860
P1433
P1476
Antiretroviral medication adhe ...... fic antiretroviral resistance.
@en
P2093
Edward M Gardner
John F Steiner
Peter L Anderson
William J Burman
P2860
P304
P356
10.1097/QAD.0B013E32832BA8EC
P407
P577
2009-06-01T00:00:00Z